Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo

PLoS Genetics

Volumn 5, Issue 6, 2009, Pages

  Ren, Yunqing ^a,b   Yang, Sen ^a,b   Xu, Shengxin ^a,b   Gao, Min ^a,b   Huang, Wei ^c   Gao, Tianwen ^d   Fang, Qiaoyun ^a,b   Quan, Cheng ^a,b   Zhang, Chi ^a,b   Sun, Liangdan ^a,b   Liang, Yanhua ^a,b   Han, Jianwen ^a,b   Wang, Zhimin ^c   Zhang, Fengyu ^a,b   Zhou, Youwen ^a,b,e   Liu, Jianjun ^a,b,f   Zhang, Xuejun ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; HLA-DRB1 ANTIGEN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DEFECT; TRANSCRIPTION REGULATION; VITILIGO; ADOLESCENT; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; VITILIGO; YOUNG ADULT;

EID: 67651233779     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000523     Document Type: Article

References (43)

1. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, et al. (2003) A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72: 1560-1564. (Pubitemid 36628395)
2. Zhang XJ, Liu JB, Gui JP, Li M, Xiong QG, et al. (2004) Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol 51: 383-390. (Pubitemid 39178665)
3. Yang S, Wang JY, Gao M, Liu HS, Sun LD, et al. (2005) Association of HLADQA1 and DQB1 genes with vitiligo in Chinese Hans. Int J Dermatol 44: 1022-1027. (Pubitemid 43046121)
4. Nath SK, Kelly JA, Namjou B, Lam T, Bruner GR, et al. (2001) Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligorelated systemic lupus erythematosus. Am J Hum Genet 69: 1401-1406. (Pubitemid 33124222)
5. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, et al. (2002) Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 11: 661-667. (Pubitemid 34285137)
6. Spritz RA, Gowan K, Bennett DC, Fain PR (2004) Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 74: 188-191. (Pubitemid 38085251)
7. Chen JJ, Huang W, Gui JP, Yang S, Zhou FS, et al. (2005) A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am J Hum Genet 76: 1057-1065. (Pubitemid 40705439)
8. Liang Y, Yang S, Zhou Y, Gui J, Ren Y, et al. (2007) Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families. J Invest Dermatol 127: 2552-2557. (Pubitemid 47585064)
9. Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20: 271-278. (Pubitemid 47057312)
10. Rezaei N, Gavalas NG, Weetman AP, Kemp EH (2007) Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 21: 865-876.
11. Tazi-Ahnini R, McDonagh AJ, Wengraf DA, Lovewell TR, Vasilopoulos Y, et al. (2008) The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol 159: 591-596.
12. Alkhateeb A, Fain PR, Spritz RA (2005) Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo. J Invest Dermatol 125: 388-391. (Pubitemid 41648176)
13. LaBerge GS, Bennett DC, Fain PR, Spritz RA (2008) PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 128: 1757-1762.
14. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, et al. (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356: 1216-1225. (Pubitemid 46465597)
15. Liou HC, Boothby MR, Finn PW, Davidon R, Nabavi N, et al. (1990) A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science 247: 1581-1584. (Pubitemid 20150836)
16. Tastan HB, Akar A, Orkunoglu FE, Arca E, Inal A (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 17: 181-184. (Pubitemid 38419646)
17. Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, et al. (2001) Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 145: 90-94. (Pubitemid 32862792)
18. Fain PR, Babu SR, Bennett DC, Spritz RA (2006) HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 19: 51-57.
19. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, et al. (2003) Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35: 171-175. (Pubitemid 37187636)
20. Cichon S, Buervenich S, Kirov G, Akula N, Dimitrova A, et al. (2004) Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nat Genet 36: 783-784; author reply 784-785. (Pubitemid 39014088)
21. Masui T, Hashimoto R, Kusumi I, Suzuki K, Tanaka T, et al. (2006) A possible association between the 2116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. Int J Neuropsychopharmacol 9: 83-88. (Pubitemid 43068337)
22. Hou SJ, Yen FC, Cheng CY, Tsai SJ, Hong CJ (2004) X-box binding protein 1 (XBP1) C-116G polymorphisms in bipolar disorders and age of onset. Neurosci Lett 367: 232-234.
23. Kakiuchi C, Ishiwata M, Umekage T, Tochigi M, Kohda K, et al. (2004) Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin Neurosci 58: 438-440. (Pubitemid 39108548)
24. Jonsson EG, Cichon S, Schumacher J, Abou Jamra R, Schulze TG, et al. (2006) Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141: 71-75. (Pubitemid 43062546)
25. Watanabe Y, Fukui N, Muratake T, Amagane H, Kaneko N, et al. (2006) Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia. Psychiatry Clin Neurosci 60: 633-635. (Pubitemid 44337488)
26. Chen W, Duan S, Zhou J, Sun Y, Zheng Y, et al. (2004) A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect. Biochem Biophys Res Commun 319: 866-870. (Pubitemid 38739401)
27. Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, et al. (2000) An essential role in liver development for transcription factor XBP-1. Genes Dev 14: 152-157. (Pubitemid 30070980)
28. Clauss IM, Gravallese EM, Darling JM, Shapiro F, Glimcher MJ, et al. (1993) In situ hybridization studies suggest a role for the basic region-leucine zipper protein hXBP-1 in exocrine gland and skeletal development during mouse embryogenesis. Dev Dyn 197: 146-156.
29. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, et al. (2004) XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 64: 5943-5947. (Pubitemid 39129389)
30. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, et al. (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307. (Pubitemid 32691837)
31. Lee AH, Chu GC, Iwakoshi NN, Glimcher LH (2005) XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands. Embo J 24: 4368-4380.
32. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891. (Pubitemid 34084979)
33. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, et al. (2007) XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 27: 53-66. (Pubitemid 46991391)
34. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, et al. (2004) XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93. (Pubitemid 38925269)
35. Lee AH, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23: 7448-7459.
36. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461. (Pubitemid 39372439)
37. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743-756.
38. Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M, et al. (2007) The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 11: 349-360. (Pubitemid 46518314)
39. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
40. Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235.
41. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. (Pubitemid 47330214)
42. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
43. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)